News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 274
- Sources here
- 21
- Companies here
- 19
Search results
Stored financial headlines
Active search
274 matching headlines
Ticker or company: POLYMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Polyrizon Ltd (PLRZ) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Polyrizon Ltd (PLRZ), detailing future EPS and revenue growth estimates. It includes a snapshot of the company's stock performance, market capitalization, and a peer comparison with other companies in the Biotechnology & Medical Research sector. The content …
PLRZ
main company
Sharemaestro market context
Price below Trend Line
52 weeks +69.4%
PolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule (NASDAQ: PYPD
PolyPid's D-PLEX₁₀₀, a drug candidate for preventing surgical site infections, has received New Drug Application (NDA) acceptance and Priority Review from the FDA, significantly shortening its target review timeline. This positive development comes shortly after PolyPid secured an exclusive commercialization partnership with Azurity Pharmaceuticals, …
PYPD
main company
Sharemaestro market context
Trend signal active
52 weeks +35.4% · Next-week setup positive 58.0%
PolyPid to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026
PolyPid Ltd. announced it will release its second quarter 2026 financial results and operational highlights on August 12, 2026, before U.S. market opening, followed by a conference call and webcast at 8:30 AM ET. The company will discuss the successful Phase 3 SHIELD II …
PYPD
main company
Sharemaestro market context
Trend signal active
52 weeks +35.4% · Next-week setup positive 58.0%
PolyPid Schedules 8:30 a.m. Webcast for Aug. 12 Results
PolyPid (Nasdaq: PYPD) announced it will report Q2 2026 financial results and operational highlights on August 12, 2026, before U.S. markets open. Management will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide a business update. …
PYPD
main company
Sharemaestro market context
Trend signal active
52 weeks +35.4% · Next-week setup positive 58.0%
PolyPid rises as lead product granted FDA priority review
PolyPid's stock increased by over 7% after the FDA granted priority review status for D-PLEX100, its lead product candidate. The FDA accepted PolyPid's New Drug Application for the Israeli biopharma company's product. This priority review indicates the potential for a faster approval process for …
PYPD
main company
Sharemaestro market context
Trend signal active
52 weeks +35.4% · Next-week setup positive 58.0%